The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Abstract
Objectives. To study the outcome at 2-year corrected age of infants who participated in a double-blind controlled trial of early (<12 hours) dexamethasone therapy for the prevention of chronic lung disease (CLD). Methods and Materials. A total of 133 children (70 in the control group, 63 in the dexamethasone-treated group) who survived the initial study period and lived to 2 years of age were studied. All infants had birth weights of 500 to 1999 g and had severe respiratory distress syndrome requiring mechanical ventilation within 6 hours after birth. For infants in the treatment group, dexamethasone was started at a mean age of 8.1 hours and given 0.25 mg/kg every 12 hours for 1 week and then tapered off gradually over a 3-week period. The following variables were evaluated: interim medical history, socioeconomic background, physical growth, neurologic examinations, mental and psychomotor development index score (MDI and PDI), pulmonary function, electroencephalogram, and auditory and visual evoked potential. Results. Infants in the control group tended to have a higher incidence of upper respiratory infection and rehospitalization than did the dexamethasone-treated group because of respiratory problems. Although there was no difference between the groups in somatic growth in girls, the dexamethasone-treated boys had significantly lower body weight and shorter height than the control boys (10.7 ± 3.0 vs 11.9 ± 2.0 kg; 84.9 ± 5.7 vs 87.5 ± 4.8 cm). The dexamethasone-treated group had a significantly higher incidence of neuromotor dysfunction (25/63 vs 12/70) than did the control group. The dexa-methasone-treated infants also had a lower PDI score (79 ± 26) than did the control group (87 ± 23), but the difference was not statistically significant. Both groups were comparable in MDI, incidence of vision impairment, and auditory and visual evoked potential. Significant handicap, defined as severe neurologic defect and/or intellectual defect (MDI and/or PDI ≤ 69), was seen in 22 children (31.4%) in the control group and 26 (41.2%) in the dexamethasone-treated group. Conclusions. Although early postnatal dexamethasone therapy for 4 weeks significantly reduces the incidence of CLD, this therapeutic regimen cannot be recommended at present because of its adverse effects on neuromotor function and somatic growth in male infants, detected at 2 years of age. A longer follow-up is needed. If early dexamethasone therapy is to be used for the prevention of CLD, the therapeutic regimen should be modified. The proper route of administration, the critical time to initiate the therapy, and the dosage and duration of therapy remain to be defined further.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Electroencephalography—Basic principles, clinical applications and related fields
(1982) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(82)90067-4 · Cited by 3,427
Social Class and Mental Illness: A Community Study
(2007) · American Journal of Public Health · doi:10.2105/ajph.97.10.1756 · Cited by 1,840
A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary Dysplasia
Cummings, J. J., D'Eugenio, D. B., & Gross, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202301 · Cited by 483
Controlled Trial of Dexamethasone in Respirator-Dependent Infants with Bronchopulmonary Dysplasia
Avery, G. B., Fletcher, A. B., Kaplan, M., & Brudno, D. S. (1985) · Pediatrics · doi:10.1542/peds.75.1.106 · Cited by 379
CONTROLLED TRIAL OF DEXAMETHASONE THERAPY IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA
Mammel, M., Johnson, D., Green, T., & Thompson, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92139-6 · Cited by 307
EFFECTS OF CORTICOSTEROIDS ON THE BIOCHEMICAL MATURATION OF RAT BRAIN: POSTNATAL CELL FORMATION
Cotterrell, M., Balaazs, R., & Johnson, A. L. (1972) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1972.tb05124.x · Cited by 204
Yeh, T. F., Lin, Y. J., Hsieh, W. S., Lin, H. C., Lin, C. H., Chen, J. Y., Kao, H. A., & Chien, C. H. (1997) · Pediatrics · doi:10.1542/peds.100.4.e3 · Cited by 184
Self-citationAntenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants
Ment, L. R., Oh, W., Ehrenkranz, R. A., Philip, A. G. S., Duncan, C. C., & Makuch, R. W. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90001-2 · Cited by 167
Brozanski, B. S., Jones, J., Gilmour, C., Balsan, M. J., Vazquez, R. L., Israel, B. A., Newman, B., Mimouni, F. B., & Guthrie, R. D. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70410-8 · Cited by 121
Weichsel, M. E. (1977) · Annals of Neurology · doi:10.1002/ana.410020503 · Cited by 120
Cited by
Ehrenkranz, R. A., Dusick, A. M., Vohr, B. R., Wright, L. L., Wrage, L. A., Poole, W. K., & for the National Institutes of Child Health and Human Development Neonatal Research Network (2006) · Pediatrics · doi:10.1542/peds.2005-1368 · Cited by 1,356
Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia
Ehrenkranz, R. A., Walsh, M. C., Vohr, B. R., Jobe, A. H., Wright, L. L., Fanaroff, A. A., Wrage, L. A., Poole, K., & for the National Institutes of Child Health and Human Development Neonatal Research Network (2005) · Pediatrics · doi:10.1542/peds.2005-0249 · Cited by 1,146
Outcomes of children of extremely low birthweight and gestational age in the 1990's
Hack, M., & Fanaroff, A. A. (1999) · Early Human Development · doi:10.1016/s0378-3782(98)00052-8 · Cited by 695
Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity
Yeh, T. F., Lin, Y. J., Lin, H. C., Huang, C. C., Hsieh, W. S., Lin, C. H., & Tsai, C. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032089 · Cited by 596
Self-citationVlachos, A., Ball, S., Dahl, N., Alter, B. P., Sheth, S., Ramenghi, U., Meerpohl, J., Karlsson, S., Liu, J. M., Leblanc, T., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07269.x · Cited by 478
Postnatal Corticosteroids to Treat or Prevent Chronic Lung Disease in Preterm Infants
Committee on Fetus and Newborn (2002) · Pediatrics · doi:10.1542/peds.109.2.330 · Cited by 442
Wood, N. S., Costeloe, K., Gibson, A. T., Hennessy, E. M., Marlow, N., & Wilkinson, A. R. (2005) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2004.052407 · Cited by 424
Barrington, K. J. (2001) · BMC Pediatrics · doi:10.1186/1471-2431-1-1 · Cited by 421
Claud, E. C., & Walker, W. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0833hyp · Cited by 413
Vohr, B. R., Wright, L. L., Poole, W. K., McDonald, S. A., & for the NICHD Neonatal Research Network Follow-up Study (2005) · Pediatrics · doi:10.1542/peds.2004-2247 · Cited by 388
Murphy, B. P., Inder, T. E., Huppi, P. S., Warfield, S., Zientara, G. P., Kikinis, R., Jolesz, F. A., & Volpe, J. J. (2001) · Pediatrics · doi:10.1542/peds.107.2.217 · Cited by 369
Outcomes of children of extremely low birthweight and gestational age in the 1990s
Hack, M., & Fanaroff, A. A. (2000) · Seminars in Neonatology · doi:10.1053/siny.1999.0001 · Cited by 368
Hack, M., Wilson-Costello, D., Friedman, H., Taylor, G. H., Schluchter, M., & Fanaroff, A. A. (2000) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.154.7.725 · Cited by 358
Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.168.3.356 · Cited by 338
Long-term outcomes after repeat doses of antenatal corticosteroids
Wapner, R. J., Sorokin, Y., Mele, L., Johnson, F., Dudley, D. J., Spong, C. Y., Peaceman, A. M., Leveno, K. J., Malone, F., Caritis, S. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071453 · Cited by 336
Glucocorticoids and lung development in the fetus and preterm infant
Bolt, R. J., van Weissenbruch, M. M., Lafeber, H. N., & Delemarre‐van de Waal, H. A. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1092 · Cited by 305
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H., Ehrenkranz, R., & Doyle, L. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146 · Cited by 303
Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146.pub2 · Cited by 298
Perlman, J. M. (2001) · Pediatrics · doi:10.1542/peds.108.6.1339 · Cited by 297
Multiple courses of antenatal corticosteroids and outcome of premature neonates
Banks, B. A., Cnaan, A., Morgan, M. A., Parer, J. T., Merrill, J. D., Ballard, P. L., & Ballard, R. A. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70517-x · Cited by 280
Center Differences and Outcomes of Extremely Low Birth Weight Infants
Vohr, B. R., Wright, L. L., Dusick, A. M., Perritt, R., Poole, W. K., Tyson, J. E., Steichen, J. J., Bauer, C. R., Wilson-Costello, D. E., Mayes, L. C., et al. (2004) · Pediatrics · doi:10.1542/peds.113.4.781 · Cited by 277
Doyle, L. W., Cheong, J. L., Ehrenkranz, R. A., & Halliday, H. L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146.pub5 · Cited by 260
Neurodevelopmental Outcome of Bronchopulmonary Dysplasia
Anderson, P. J., & Doyle, L. W. (2006) · Seminars in Perinatology · doi:10.1053/j.semperi.2006.05.010 · Cited by 252
Corticosteroids in the prevention and management of bronchopulmonary dysplasia
Grier, D. G., & Halliday, H. L. (2003) · Seminars in Neonatology · doi:10.1016/s1084-2756(02)00189-6 · Cited by 51
Metadata
- Authors
- Yeh, T. F., Lin, Y. J., Huang, C. C., Chen, Y. J., Lin, C. H., Lin, H. C., Hsieh, W. S., & Lien, Y. J.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1998-05-01
- Volume
- 101
- Issue
- 5
- Pages
- e7-e7
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2052191146
- Cited by
- 418
- References
- 13
- FWCI
- 26.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.